Bluejay Diagnostics (BJDX) Cost of Revenue (2022 - 2023)

Bluejay Diagnostics' Cost of Revenue history spans 2 years, with the latest figure at $154329.0 for Q2 2023.

  • For Q2 2023, Cost of Revenue rose 89.69% year-over-year to $154329.0; the TTM value through Jun 2023 reached $367462.0, changed N/A, while the annual FY2024 figure was $8297.0, 97.07% down from the prior year.
  • Cost of Revenue for Q2 2023 was $154329.0 at Bluejay Diagnostics, up from $148046.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $154329.0 in Q2 2023 and bottomed at $53685.0 in Q1 2022.